7.80Open7.80Pre Close0 Volume6 Open Interest25.00Strike Price0.00Turnover129.73%IV6.16%PremiumJan 17, 2025Expiry Date6.67Intrinsic Value100Multiplier23DDays to Expiry1.13Extrinsic Value100Contract SizeAmericanOptions Type-0.7844Delta0.0497Gamma2.53Leverage Ratio-0.0359Theta-0.0109Rho-1.98Eff Leverage0.0135Vega
Pulse Biosciences Stock Discussion
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study With Its Nano-Pfa Cardiac Surgery System
1 MINUTE AGO, 8:00 AM EST
VIA BUSINESSWIRE
No comment yet